Status:
UNKNOWN
Comparative Evaluation of Covid-19 Vaccines Response
Lead Sponsor:
Karamanoğlu Mehmetbey University
Conditions:
COVID-19 Vaccines
Eligibility:
All Genders
18-99 years
Brief Summary
Study Population Population with vaccinated with three different Covid Vaccines (Inactive Vaccine (Sinovac Life Sciences, Beijing, China), recombinant human adenovirus serotype number 26 (rAd26 of Sp...
Detailed Description
Aim of Study * to evaluate Anti-SARS-CoV-2 IgG Antibody and Neutralizing Antibody response in different Vaccine Groups * to evaluate progression of the vaccine response after 2, 6, and 12 Months afte...
Eligibility Criteria
Inclusion
- \- Any person, male or female, over 18 years of age.
- The patient has signed an informed consent form.
- The patient was vaccinated with SARS-CoV-2 vaccine.
Exclusion
- Inability to give clear information (person in an emergency, difficulty understanding the subject, etc.)
- Person under safeguard of justice
- Person under guardianship or curator ship.
Key Trial Info
Start Date :
June 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2022
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT04895007
Start Date
June 1 2021
End Date
June 1 2022
Last Update
July 15 2021
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Karamanoglu Mehmetbey University
Karaman, Turkey (Türkiye), 70200
2
Selcuk University
Konya, Turkey (Türkiye), 42250
3
Tekirdag Namık Kemal University, Faculty of Medicine
Tekirdağ, Turkey (Türkiye)
4
Karadeniz Technic University, Faculty of Medicine
Trabzon, Turkey (Türkiye)